Hepatic steatosis is one of the earliest detectable manifestations of metabolic dysfunction-associated liver disease. Therefore, identifying hepatic steatosis is an important aspect of contemporary metabolic liver care. APPs are often... Read More
Author: MASLD
As clinicians work through the challenges posed by the overlap of metabolic dysfunction and alcohol-related liver injury, the importance of advanced practice providers (APPs) and MetALD assessment has increased. Metabolic... Read More
As MASH transforms metabolic liver care, MASH Clinical Guidelines for APPs are crucial for integrating structured, evidence-based metabolic liver care. MASH is quickly becoming a leading cause for advanced liver... Read More
As metabolic dysfunction–associated steatotic liver disease (MASLD) becomes a growing concern for providers, the need for training in MASLD management for Advanced Practice Providers (APPs) becomes apparent. APPs are frontline... Read More